Finance Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Finance Industry Today.

Press releases published on September 3, 2026

Sep. 3, 2026

Ambarella, Inc. Announces Second Quarter Fiscal Year 2027 Financial Results

Indeterminate GlobeNewswire

Sep. 3, 2026

XPO Provides North American LTL Operating Data for August 2026

Indeterminate GlobeNewswire

Sep. 3, 2026

Nasdaq Reports August 2026 Volumes

Indeterminate GlobeNewswire

Sep. 3, 2026

Oxford: Owner of Tommy Bahama, Lilly Pulitzer and Johnny Was Reports Second Quarter Results

Indeterminate GlobeNewswire

Sep. 3, 2026

Zscaler Announces Strong Fourth Quarter and Fiscal 2026 Financial Results

Indeterminate GlobeNewswire

Sep. 3, 2026

U.S. Global Investors Reports $3.1 Million in Net Income for Fiscal Year 2026

Indeterminate GlobeNewswire

Sep. 3, 2026

Vaxcyte Appoints Chief Medical Officer and Chief Legal Officer; Narrows Guidance for Expected VAX-31 OPUS-1 Topline Data

Indeterminate GlobeNewswire

Sep. 3, 2026

Alector to Participate in Upcoming Healthcare Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Concrete Pumping Holdings Reports Strong Third Quarter Fiscal Year 2026 Results and Initiates Quarterly Dividend

Indeterminate GlobeNewswire

Sep. 3, 2026

eGain Reports Fiscal 2026 Results: Total Revenue Up 3%, AI Customer Revenue Up 20%, Company Named a Leader in Gartner's First Customer Service Knowledge Management MQ

Indeterminate GlobeNewswire

Sep. 3, 2026

Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 3, 2026

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 3, 2026

Reliance Global Group Adopts One-Year Stockholder Rights Plan to Protect Stockholder Value

Indeterminate GlobeNewswire

Sep. 3, 2026

Pasithea Therapeutics Announces Participation in Two September 2026 Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 3, 2026

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 3, 2026

Arvinas to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Hooker Furnishings Declares Quarterly Dividend

Indeterminate GlobeNewswire

Sep. 3, 2026

Rein Therapeutics to Present at Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Frequency Electronics Announces First Quarter Fiscal 2027 Financial Results Conference Call: Thursday, September 10, 2026, at 4:30 PM ET

Indeterminate GlobeNewswire